Cerebrolysin Ameliorates Focal Cerebral Ischemia Injury Through Neuroinflammatory Inhibition via CREB/PGC-1α Pathway
Neuroinflammation is one of the important factors aggravating brain injury after ischemic stroke. We aimed to investigate the effects of cerebrolysin (CBL) on neuroinflammation in vivo and in vitro and the underlying mechanisms. The gene expressions of pro-inflammatory factors and anti-inflammatory...
Main Authors: | Xin Guan, Yunjie Wang, Guoyin Kai, Shunyi Zhao, Tingyu Huang, Youzhen Li, Yuan Xu, Luyong Zhang, Tao Pang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-10-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fphar.2019.01245/full |
Similar Items
-
Using of cerebrolysin in patients with epilepsy
by: A. S. Kotov
Published: (2018-04-01) -
PERSPECTIVES OF THERAPY WITH CEREBROLYSIN IN NEUROLOGY AND ITS PLACE IN CLINICAL PRACTICE OF PEDIATRIC NEUROLOGY
by: A. S. Petrukhin, et al.
Published: (2015-07-01) -
Cerebrolysin as a New Treatment Option for Post-Stroke Spasticity: Patient and Physician Perspectives
by: Nataliia Chemer, et al.
Published: (2019-02-01) -
Effect of cerebrolysin on motor function restoration during medical rehabilitation
by: M. A. Kustova, et al.
Published: (2016-07-01) -
Effects of Cerebrolysin on Hippocampal Neuronal Death After Pilocarpine-Induced Seizure
by: Dong Hyeon Kang, et al.
Published: (2020-10-01)